Procalcitonin serum concentrations after different types of general and visceral surgery

• Conditions: C25; C18; Other nontoxic goitre; Malignant neoplasm of stomach; Malignant neoplasm of pancreas; E04; C16; Malignant neoplasm of rectum; C20; K57.30

• Registration Number: DRKS00005703
• Lead Sponsor: HELIOS Klinikum ErfurtKlinik für Allgemein- und Viszeralchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02-18
• Study Completion: 2015-08-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

One of the following surgical procederes (conventional/laparoscopic) is planned:
- thyroid resection
- gastric resection
- pancreatic resection
- liver resection
- colorectal resection

- taking of bloodsamples has to be ensured for the first five postoperative days

Exclusion Criteria

- liver cirrhosis
- presence of an acute inflammatory process
- medullary thyroid cancer

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measurement of PCT serum-levels on the first five postoperative days

Secondary Outcome Measures

Name	Time	Method
- Measurement of CRP levels and number of leucocytes on the first five postoperative days. This is performed to evaluate differences between procalcitonin and these parameters.<br><br>- Relationship between increase of pct-levels and postoperative complications<br><br>- Relationship between increase of parameters (PCT, CRP und leukocytes) and postopertive SIRS. For that reason also SIRS parameters are detected.